N-AVD treatment in older cHL patients shows high efficacy with 79% progression-free and 97% overall survival rates at three years. The regimen is well-tolerated, with low rates of immune-related side ...

These chemicals include plastic & rubber additives, oilfield chemicals, water treatment chemicals ... Now is American Vanguard Corporation (NYSE:AVD). It develops and markets specialty chemicals ...